DaVita
DVA
#1796
Rank
NZ$20.95 B
Marketcap
NZ$333.22
Share price
-2.30%
Change (1 day)
56.03%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2023 (TTM): NZ$8.49

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$24.74. In 2022 the company made an earnings per share (EPS) of NZ$10.66 a decrease over its 2021 EPS that were of NZ$16.54.

EPS history for DaVita from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$8.49-20.31%
2022NZ$10.66-35.56%
2021NZ$16.5444.1%
2020NZ$11.4819.7%
2019NZ$9.59540.48%
2018NZ$1.50-76.07%
2017NZ$6.26-19.31%
2016NZ$7.75242.52%
2015NZ$2.26-62.87%
2014NZ$6.1013.43%
2013NZ$5.378.45%
2012NZ$4.969.66%
2011NZ$4.5227.07%
2010NZ$3.56-2.44%
2009NZ$3.6514.57%
2008NZ$3.18-1.38%
2007NZ$3.2329.75%
2006NZ$2.4922.37%
2005NZ$2.030.88%
2004NZ$2.0129.89%
2003NZ$1.5523.7%
2002NZ$1.2539.72%
2001NZ$0.90788.84%
2000NZ$0.10-109.88%
1999NZ-$1.021046.52%
1998NZ-$0.08913-123.43%
1997NZ$0.3877.78%
1996NZ$0.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$43.07 74.06%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$21.87-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$61.87 150.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.36-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA